Pharma Deals Review, Vol 2005, No 62 (2005)

Font Size:  Small  Medium  Large

Salix to Acquire InKine in Gastrointestinal Merger

Business Review Editor

Abstract


Salix Pharmaceuticals acquired InKine Pharmaceutical thereby strengthening itself in the area of gastrointestinal diseases. The acquisition deal could be worth up to US$190 M to InKine.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.